Tumour Microenvironment Stress Promotes the Development of Drug Resistance

Multi-drug resistance (MDR) is a leading cause of cancer-related death, and it continues to be a major barrier to cancer treatment. The tumour microenvironment (TME) has proven to play an essential role in not only cancer progression and metastasis, but also the development of resistance to chemothe...

Full description

Bibliographic Details
Main Authors: Nicole A. Seebacher, Maria Krchniakova, Alexandra E. Stacy, Jan Skoda, Patric J. Jansson
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/11/1801
_version_ 1827677511569375232
author Nicole A. Seebacher
Maria Krchniakova
Alexandra E. Stacy
Jan Skoda
Patric J. Jansson
author_facet Nicole A. Seebacher
Maria Krchniakova
Alexandra E. Stacy
Jan Skoda
Patric J. Jansson
author_sort Nicole A. Seebacher
collection DOAJ
description Multi-drug resistance (MDR) is a leading cause of cancer-related death, and it continues to be a major barrier to cancer treatment. The tumour microenvironment (TME) has proven to play an essential role in not only cancer progression and metastasis, but also the development of resistance to chemotherapy. Despite the significant advances in the efficacy of anti-cancer therapies, the development of drug resistance remains a major impediment to therapeutic success. This review highlights the interplay between various factors within the TME that collectively initiate or propagate MDR. The key TME-mediated mechanisms of MDR regulation that will be discussed herein include (1) altered metabolic processing and the reactive oxygen species (ROS)-hypoxia inducible factor (HIF) axis; (2) changes in stromal cells; (3) increased cancer cell survival via autophagy and failure of apoptosis; (4) altered drug delivery, uptake, or efflux and (5) the induction of a cancer stem cell (CSC) phenotype. The review also discusses thought-provoking ideas that may assist in overcoming the TME-induced MDR. We conclude that stressors from the TME and exposure to chemotherapeutic agents are strongly linked to the development of MDR in cancer cells. Therefore, there remains a vast area for potential research to further elicit the interplay between factors existing both within and outside the TME. Elucidating the mechanisms within this network is essential for developing new therapeutic strategies that are less prone to failure due to the development of resistance in cancer cells.
first_indexed 2024-03-10T05:45:01Z
format Article
id doaj.art-43e84d073fb342e788c5a920837cdce9
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T05:45:01Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-43e84d073fb342e788c5a920837cdce92023-11-22T22:13:54ZengMDPI AGAntioxidants2076-39212021-11-011011180110.3390/antiox10111801Tumour Microenvironment Stress Promotes the Development of Drug ResistanceNicole A. Seebacher0Maria Krchniakova1Alexandra E. Stacy2Jan Skoda3Patric J. Jansson4Department of Oncology, University of Oxford, Oxford OX3 9DU, UKDepartment of Experimental Biology, Faculty of Science, Masaryk University, 62500 Brno, Czech RepublicCancer Drug Resistance & Stem Cell Program, School of Medical Science, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, AustraliaDepartment of Experimental Biology, Faculty of Science, Masaryk University, 62500 Brno, Czech RepublicCancer Drug Resistance & Stem Cell Program, School of Medical Science, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, AustraliaMulti-drug resistance (MDR) is a leading cause of cancer-related death, and it continues to be a major barrier to cancer treatment. The tumour microenvironment (TME) has proven to play an essential role in not only cancer progression and metastasis, but also the development of resistance to chemotherapy. Despite the significant advances in the efficacy of anti-cancer therapies, the development of drug resistance remains a major impediment to therapeutic success. This review highlights the interplay between various factors within the TME that collectively initiate or propagate MDR. The key TME-mediated mechanisms of MDR regulation that will be discussed herein include (1) altered metabolic processing and the reactive oxygen species (ROS)-hypoxia inducible factor (HIF) axis; (2) changes in stromal cells; (3) increased cancer cell survival via autophagy and failure of apoptosis; (4) altered drug delivery, uptake, or efflux and (5) the induction of a cancer stem cell (CSC) phenotype. The review also discusses thought-provoking ideas that may assist in overcoming the TME-induced MDR. We conclude that stressors from the TME and exposure to chemotherapeutic agents are strongly linked to the development of MDR in cancer cells. Therefore, there remains a vast area for potential research to further elicit the interplay between factors existing both within and outside the TME. Elucidating the mechanisms within this network is essential for developing new therapeutic strategies that are less prone to failure due to the development of resistance in cancer cells.https://www.mdpi.com/2076-3921/10/11/1801tumour microenvironmental stressdrug resistancereactive oxygen speciescancer stem cells
spellingShingle Nicole A. Seebacher
Maria Krchniakova
Alexandra E. Stacy
Jan Skoda
Patric J. Jansson
Tumour Microenvironment Stress Promotes the Development of Drug Resistance
Antioxidants
tumour microenvironmental stress
drug resistance
reactive oxygen species
cancer stem cells
title Tumour Microenvironment Stress Promotes the Development of Drug Resistance
title_full Tumour Microenvironment Stress Promotes the Development of Drug Resistance
title_fullStr Tumour Microenvironment Stress Promotes the Development of Drug Resistance
title_full_unstemmed Tumour Microenvironment Stress Promotes the Development of Drug Resistance
title_short Tumour Microenvironment Stress Promotes the Development of Drug Resistance
title_sort tumour microenvironment stress promotes the development of drug resistance
topic tumour microenvironmental stress
drug resistance
reactive oxygen species
cancer stem cells
url https://www.mdpi.com/2076-3921/10/11/1801
work_keys_str_mv AT nicoleaseebacher tumourmicroenvironmentstresspromotesthedevelopmentofdrugresistance
AT mariakrchniakova tumourmicroenvironmentstresspromotesthedevelopmentofdrugresistance
AT alexandraestacy tumourmicroenvironmentstresspromotesthedevelopmentofdrugresistance
AT janskoda tumourmicroenvironmentstresspromotesthedevelopmentofdrugresistance
AT patricjjansson tumourmicroenvironmentstresspromotesthedevelopmentofdrugresistance